Sygnature Discovery(@SygnatureDiscov) 's Twitter Profileg
Sygnature Discovery

@SygnatureDiscov

Sygnature Discovery is a world-leading integrated drug discovery provider.

ID:2420800531

linkhttp://www.sygnaturediscovery.com calendar_today31-03-2014 16:38:21

1,3K Tweets

1,8K Followers

259 Following

Follow People
Sygnature Discovery(@SygnatureDiscov) 's Twitter Profile Photo

Today, we are delighted to announce the acquisition of one of North America’s largest discovery Contract Research Organisations—Canada-based NuChem Sciences.

Read the full press release (also available in French and Japanese):

👉info.sygnaturediscovery.com/a-new-discovery

account_circle
Sygnature Discovery(@SygnatureDiscov) 's Twitter Profile Photo

Join Dr Roland Hjerpe and Dr Allan Jordan as they discuss hit generation and profiling strategies for targeted protein degradation (TPD) projects at a premium CRO. Don't miss this insightful webinar! Register now: lnkd.in/evhhqKCQ

Join Dr Roland Hjerpe and Dr Allan Jordan as they discuss hit generation and profiling strategies for targeted protein degradation (TPD) projects at a premium CRO. Don't miss this insightful webinar! Register now: lnkd.in/evhhqKCQ #TPD #SGL #degraders #drugdiscovery
account_circle
Sygnature Discovery(@SygnatureDiscov) 's Twitter Profile Photo

Join us tomorrow with Jamie Scott, Director of Medicinal Chemistry at AstraZeneca as he describes two distinct approaches toward the degradation of Era (estrogen receptor alpha)

 Register for the free live webinar here: lnkd.in/erccFa7h

Join us tomorrow with Jamie Scott, Director of Medicinal Chemistry at AstraZeneca as he describes two distinct approaches toward the degradation of Era (estrogen receptor alpha)  Register for the free live webinar here: lnkd.in/erccFa7h #medchem #drugdiscovery #biotech
account_circle
Sygnature Discovery(@SygnatureDiscov) 's Twitter Profile Photo

Join our Targeted Protein Degradation live webinar series on May 10th with Jamie Scott, Director of Medicinal Chemistry AstraZeneca.

Register here to gain exclusive insights from expert drug hunters:info.sygnaturediscovery.com/targeted-prote…

account_circle
Sygnature Discovery(@SygnatureDiscov) 's Twitter Profile Photo

Sygnature Discovery's CEO, Simon Hirst, shares insights on finding the right start points and properties for success in targeted protein degradation.
Learn about the CHARMED platform from Sygnature Discovery for rapid degrader assessment: lnkd.in/esQZKTFc

account_circle
Sygnature Discovery(@SygnatureDiscov) 's Twitter Profile Photo

What if you could rapidly assess the feasibility of a degrader project for your protein of interest?
Welcome to CHARMED from Sygnature Discovery...

👉lnkd.in/e5eCMpxK

account_circle
Sygnature Discovery(@SygnatureDiscov) 's Twitter Profile Photo

On we're sharing 3 current trends in the field of kidney health and treatment:

🔵 AI & machine learning to identify new drug targets
🔵 In Vitro-In Vivo modelling
🔵 Novel solutions to improve kidney health

Which do you think will make the biggest impact?

account_circle
Sygnature Discovery(@SygnatureDiscov) 's Twitter Profile Photo

Sygnature Discovery continues its expansion and investment by opening further dedicated laboratories at Alderley Park. This new space will provide increased capacity for up to an additional 130 scientists!

account_circle
Sygnature Discovery(@SygnatureDiscov) 's Twitter Profile Photo

Fantastic for Sygnature Discovery to be partnering this programme which supports UK breakthroughs in . And for Jane Kendrew, our Director of Translational Oncology, to be on the Programme Faculty Panel.

account_circle
Sygnature Discovery(@SygnatureDiscov) 's Twitter Profile Photo

Thank you Drug Hunter for featuring Compound 27 CTPS1/2 in 'Small Molecules of the Month'! This was a collaboration between biotech Step Pharma and the drug discovery team at Sygnature Discovery. Read more here:

bit.ly/3Z6S5Uh

drug hunter

account_circle
Sygnature Discovery(@SygnatureDiscov) 's Twitter Profile Photo

Despite an intense effort, does the rising global incidence of indicate a failure of the drug discovery process?

Thanks to Steven - our Director of In-vivo pharmacology - for today's insights: lnkd.in/eQywMqgp

World Diabetes Day Diabetes UK

account_circle
Sygnature Discovery(@SygnatureDiscov) 's Twitter Profile Photo

As members from our team prepare for 2022 conference in San Diego, Dr. Max Mirza - our VP of Neuroscience - looks at the mission to help patients fight . Read more on our blog: bit.ly/3DUycHs
Society for Neuroscience (SfN)

account_circle
Sygnature Discovery(@SygnatureDiscov) 's Twitter Profile Photo

'The current thinking is that a third of cancers might be preventable, but I believe this is a significant understatement.'

The NHS's campaign is almost at an end, but it's never too late to quit smoking. Our VP of shares his thoughts bit.ly/3gN2UsY

account_circle
Sygnature Discovery(@SygnatureDiscov) 's Twitter Profile Photo

hubs.la/Q01qF9ZN0

Just under 3 weeks until our CEO - Simon Hirst – takes part in the ! The Nottingham arm of this national charity event will see CEOs sleeping out at Meadow Lane Football ground to raise money for the homeless. Please donate if you can!

account_circle
Sygnature Discovery(@SygnatureDiscov) 's Twitter Profile Photo

It's ! Let's keep working together to ensure a brighter future for all. Check out the initiative's website here: worldcancerresearchday.com

account_circle